生物
髓样
人口
髓系细胞
转录组
细胞
免疫疗法
肺癌
树突状细胞
单细胞分析
免疫学
基因
癌症研究
癌症
遗传学
病理
免疫系统
基因表达
社会学
人口学
医学
作者
Rapolas Žilionis,Camilla Engblom,Christina Pfirschke,Virginia Savova,David Zemmour,Hatice D. Saatcioglu,Indira Krishnan,Giorgia Maroni,Claire V. Meyerovitz,Clara M. Kerwin,Sun Kil Choi,William G. Richards,Assunta De Rienzo,Daniel G. Tenen,Raphael Bueno,Elena Levantini,Mikaël J. Pittet,Allon M. Klein
出处
期刊:Immunity
[Cell Press]
日期:2019-04-09
卷期号:50 (5): 1317-1334.e10
被引量:1178
标识
DOI:10.1016/j.immuni.2019.03.009
摘要
Tumor-infiltrating myeloid cells (TIMs) comprise monocytes, macrophages, dendritic cells, and neutrophils, and have emerged as key regulators of cancer growth. These cells can diversify into a spectrum of states, which might promote or limit tumor outgrowth but remain poorly understood. Here, we used single-cell RNA sequencing (scRNA-seq) to map TIMs in non-small-cell lung cancer patients. We uncovered 25 TIM states, most of which were reproducibly found across patients. To facilitate translational research of these populations, we also profiled TIMs in mice. In comparing TIMs across species, we identified a near-complete congruence of population structures among dendritic cells and monocytes; conserved neutrophil subsets; and species differences among macrophages. By contrast, myeloid cell population structures in patients' blood showed limited overlap with those of TIMs. This study determines the lung TIM landscape and sets the stage for future investigations into the potential of TIMs as immunotherapy targets.
科研通智能强力驱动
Strongly Powered by AbleSci AI